AskBio Presents Preliminary Data from Phase 1 Trial of Gene Therapy for Congestive Heart Failure (CHF) at the 2023 American Heart Association Scientific Sessions : vimarsana.com

AskBio Presents Preliminary Data from Phase 1 Trial of Gene Therapy for Congestive Heart Failure (CHF) at the 2023 American Heart Association Scientific Sessions

/PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today...

Related Keywords

United States , Philadelphia , Pennsylvania , United Kingdom , Edinburgh , City Of , Minnesota , Research Triangle Park , North Carolina , Scotland , American , Litsag Kranias , Timothyd Henry , Canwen Jiang , Steering Committee Member , Global Public Health Burden Of Heart Failure , Drug Administration , American Heart Association , American Heart Association Scientific Sessions , Centers For Disease Control , Asklepios Biopharmaceutical Inc , Trademark Office , University Of Cincinnati , Linkedin , Bayer Ag , Asklepios Biopharmaceutical , Hanna Chair , Minnesota Living , Heart Failure Questionnaire , Principal Investigator , Chief Development Officer , Chief Medical Officer , United States Food , United States Patent , Accessed November , Public Health Burden , Card Fail , Protein Phosphatase , Patients With Class , Disease Control , Heart Association , Askbio ,